CCDC50 antibody (Middle Region)
Quick Overview for CCDC50 antibody (Middle Region) (ABIN631775)
Target
See all CCDC50 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- Middle Region
-
Specificity
- CCDC50 antibody was raised against the middle region of CCDC50
-
Purification
- Affinity purified
-
Immunogen
- CCDC50 antibody was raised using the middle region of CCDC50 corresponding to a region with amino acids KAKEREKSSLDKRKQDPEWKPKTAKAANSKSKESDEPHHSKNERPARPPP
-
-
-
-
Application Notes
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
CCDC50 Blocking Peptide, (ABIN939634), is also available for use as a blocking control in assays to test for specificity of this CCDC50 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of CCDC50 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Handling Advice
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- CCDC50 (Coiled-Coil Domain Containing 50 (CCDC50))
-
Alternative Name
- CCDC50
-
Background
- CCDC50 is a soluble, cytoplasmic, tyrosine-phosphorylated protein with multiple ubiquitin-interacting domains. Mutations in this gene cause nonsyndromic, postlingual, progressive sensorineural DFNA44 hearing loss. In mouse, the protein is expressed in the inner ear during development and postnatal maturation and associates with microtubule-based structures. This protein may also function as a negative regulator of NF-kB signaling and as an effector of epidermal growth factor (EGF)-mediated cell signaling.
-
Molecular Weight
- 56 kDa (MW of target protein)
Target
-